a view to a kill – target discovery in cancer research...2019/04/12  · 1st mini-symposium in...

1
1st Mini-Symposium in Translational Oncology (MiTraC) A View to a Kill – Target Discovery in Cancer Research The UCT Mainz & Merck present April 12th · 2019 | 10:30 am – 4:00 pm University Medical Center Mainz | Building 102 · Lecture Hall Session 2: Immuno-Oncology & Microenvironment Michele Mishto · London: Is it worth to search among spliced peptides to develop anti-cancer immunotherapies? Kathrin Renner-Sattler · Regensburg: Metabolic checkpoints in the tumor microenvironment. Olivier Demaria · Marseille: Next generation immunotherapies: NK cells and other targets. Incl. Lunch, Speakers’ Corner & Get Together/Network Café More info & registration (free of charge) until 5th of April 2019 at [email protected] Session 1: Biomarkers & Molecular Oncology Tobias Sjöblom · Uppsala: Cancer Biomarkers: how should we turn defeat to victory ? Chunaram Choudhary · Kopenhagen: DNA damage repair network analysis reveals shieldin as a key regulator of NHEJ and PARP inhibitor sensitivity. Jens Siveke · Essen: Target Evaluation in Pancreatic Cancer. Foto: © Adobe Stock – Christoph Burgstedt

Upload: others

Post on 04-Feb-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

  • 1st Mini-Symposium in Translational Oncology (MiTraC)

    A View to a Kill – Target Discovery in Cancer Research

    The UCT Mainz & Merck present

    April 12th · 2019 | 10:30 am – 4:00 pmUniversity Medical Center Mainz | Building 102 · Lecture Hall

    Session 2: Immuno-Oncology & MicroenvironmentMichele Mishto · London: Is it worth to search among spliced peptides to develop anti-cancer immunotherapies?

    Kathrin Renner-Sattler · Regensburg: Metabolic checkpoints in the tumor microenvironment.

    Olivier Demaria · Marseille: Next generation immunotherapies: NK cells and other targets. Incl. Lunch, Speakers’ Corner & Get Together/Network Café

    More info & registration (free of charge) until 5th of April 2019 at [email protected]

    Session 1: Biomarkers & Molecular OncologyTobias Sjöblom · Uppsala: Cancer Biomarkers: how should we turn defeat to victory ?

    Chunaram Choudhary · Kopenhagen: DNA damage repair network analysis reveals shieldin as a key regulator of NHEJ and PARP inhibitor sensitivity.

    Jens Siveke · Essen: Target Evaluation in Pancreatic Cancer.

    Foto

    : © A

    dobe

    Sto

    ck –

    Chr

    isto

    ph B

    urgs

    tedt